The role of mGlu4 receptors within the nucleus accumbens in acquisition and expression of morphine-induced conditioned place preference in male rats

被引:0
作者
Zahra Ebrahimi
Nazanin Kahvandi
Alireza Komaki
Seyed Asaad Karimi
Marzieh Naderishahab
Abdolrahman Sarihi
机构
[1] Hamadan University of Medical Sciences,Neurophysiology Research Center
[2] Hamadan University of Medical Sciences,Department of Neuroscience, School of Sciences and Advanced Technology in Medicine
[3] Hamadan University of Medical Sciences,Department of Physiology, Faculty of Medicine
来源
BMC Neuroscience | / 22卷
关键词
Metabotropic glutamate receptor type 4; Nucleus accumbens; Conditioned place preference; Morphine; Rat;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 273 条
[1]  
Leshner AI(2003)Science Is Revolutionizing Our View of Addiction—and What to Do About It Focus 1 194-195
[2]  
Schultz W(2006)Behavioral theories and the neurophysiology of reward Annu Rev Psychol 57 87-115
[3]  
D'Souza MS(2015)Glutamatergic transmission in drug reward: implications for drug addiction Front Neurosci 9 404-114
[4]  
Haber SN(2010)The reward circuit: linking primate anatomy and human imaging Neuropsychopharmacology 35 4-23
[5]  
Knutson B(2002)Nucleus accumbens shell and core dopamine: differential role in behavior and addiction Behav Brain Res 137 75-198
[6]  
Di Chiara G(2005)Ontogeny of the dopamine innervation in the nucleus accumbens of gerbils Brain Res 1066 16-3325
[7]  
Lesting J(2015)Blockage of acquisition and expression of morphine-induced conditioned place preference in rats due to activation of glutamate receptors type II/III in nucleus accumbens Pharmacol Biochem Behav 135 192-871
[8]  
Neddens J(2002)Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways Mol Interventions 2 146-278
[9]  
Teuchert-Noodt G(2002)Neural systems underlying opiate addiction J Neurosci 22 3321-381
[10]  
Baharlouei N(2016)The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis Pharmacol Rev 68 816-63